Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Name: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
Published: 2018
License: Public Domain

Imperial College London · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

ovarian-cancer

ovarian cancer, ovarian neoplasms, ovarian carcinosarcoma, ovarian serous adenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian clear cell adenocarcinoma, fallopian tube cancer, fallopian tube neoplasms, primary peritoneal carcinoma, primary peritoneal serous adenocarcinoma, tak228, tak-228

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 850101
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.